Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Another insider purchase at $STVN This time the former CFO of $WST $274k https://t.co/gLzI7F1d42 https://t.co/SVf78aJp4S
Don Morel, former $WST CEO that sits on $STVN board, buys $325,000 worth of shares in the open market https://t.co/xxuZXxmNJB
Looks like some form of capitulation on $STVN today Trading at roughly 11x 2026 EBITDA despite significant tailwinds in the coming years Yes, 2027 is an air pocket and there's basically no catalyst on the horizon, but they'll likely still grow next year while expanding margins
Published an update on $STVN after today's earnings and drop. You can find it in the usual place https://t.co/DN4yZtZcNY
13 analysts rate STVN Buy on consensus.
Consensus price target: $19.46 (+23.16% upside from $15.80)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| FEDERICI WILLIAM J director | Nov 9, 2026 | Purchase | 20,000 | $274.4K |
| Stocchi Mauro See Remarks | Sep 28, 2026 | Sale | 13,649 | $293.45K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $1.26B | +3.21% | $148M |
| 2024 | $1.22B | +1.72% | $129.81M |
| 2023 | $1.2B | +10.34% | $160.51M |
Stock data for STVN: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics